BIOMAT Database Logo BIOMAT Database Logo

Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease. 1992

K Blennow, and A Wallin, and C G Gottfries, and A Lekman, and I Karlsson, and I Skoog, and L Svennerholm
Department of Psychiatry and Neurochemistry, Gothenburg University, St. Jörgen's Hospital Hisings Backa, Sweden.

The monoamine metabolites homovanillic acid (HVA), 5-hydroxy-indoleacetic acid (5-HIAA) and 4-hydroxy-3-methoxy-phenylglycol (HMPG) were determined in lumbar cerebrospinal fluid (CSF) of 123 patients with Alzheimer's disease (AD) and 57 healthy controls. Despite CSF sampling under strictly standardized conditions, a wide variability in values among both patients and controls was found, as well as fluctuations in repeated samples from individual patients. This suggests that several unknown factors influence the lumbar CSF levels of monoamine metabolites. The AD group showed significantly lower mean levels of HVA (p less than 0.0001) and 5-HIAA (p less than 0.0001) than the control group. A relation between severity of disease and HVA was also found. The widespread neurotransmitter disturbance in AD, together with the nonspecificity of reduced lumbar HVA and 5-HIAA levels, suggests that the changes are nonspecific, secondary to the cerebral degeneration in AD.

UI MeSH Term Description Entries
D008297 Male Males
D008734 Methoxyhydroxyphenylglycol Synthesized from endogenous epinephrine and norepinephrine in vivo. It is found in brain, blood, CSF, and urine, where its concentrations are used to measure catecholamine turnover. Hydroxymethoxyphenylglycol,MHPG,MOPEG,Vanylglycol,4-Hydroxy-3-methoxyphenylethylene Glycol,4-Hydroxy-3-methoxyphenylethyleneglycol,4-Hydroxy-3-methoxyphenylglycol,Methoxyhydroxyphenylglycol, (+)-Isomer,Methoxyhydroxyphenylglycol, (+-)-Isomer,Methoxyhydroxyphenylglycol, (-)-Isomer,4 Hydroxy 3 methoxyphenylethylene Glycol,4 Hydroxy 3 methoxyphenylethyleneglycol,4 Hydroxy 3 methoxyphenylglycol
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006719 Homovanillic Acid A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid. 3-Methoxy-4-Hydroxyphenylacetic Acid,4-Hydroxy-3-Methoxyphenylacetic Acid,3 Methoxy 4 Hydroxyphenylacetic Acid,4 Hydroxy 3 Methoxyphenylacetic Acid,Acid, 3-Methoxy-4-Hydroxyphenylacetic,Acid, 4-Hydroxy-3-Methoxyphenylacetic,Acid, Homovanillic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006897 Hydroxyindoleacetic Acid 5-HIAA,5-Hydroxy-3-Indoleacetic Acid,5-Hydroxyindolamine Acetic Acid,5 Hydroxy 3 Indoleacetic Acid,5 Hydroxyindolamine Acetic Acid,Acetic Acid, 5-Hydroxyindolamine,Acid, 5-Hydroxy-3-Indoleacetic,Acid, 5-Hydroxyindolamine Acetic,Acid, Hydroxyindoleacetic
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia

Related Publications

K Blennow, and A Wallin, and C G Gottfries, and A Lekman, and I Karlsson, and I Skoog, and L Svennerholm
CSF HVA and 5-HIAA.
June 1979, Neurology,
K Blennow, and A Wallin, and C G Gottfries, and A Lekman, and I Karlsson, and I Skoog, and L Svennerholm
Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression.
September 1985, Archives of general psychiatry,
K Blennow, and A Wallin, and C G Gottfries, and A Lekman, and I Karlsson, and I Skoog, and L Svennerholm
Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson's disease and controls.
December 2013, Journal of neurology,
K Blennow, and A Wallin, and C G Gottfries, and A Lekman, and I Karlsson, and I Skoog, and L Svennerholm
5-HIAA and HVA in CSF in patients with idiopathic pain disorders.
April 1987, Biological psychiatry,
K Blennow, and A Wallin, and C G Gottfries, and A Lekman, and I Karlsson, and I Skoog, and L Svennerholm
[Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) levels in the lumbar cerebrospinal fluid in epileptic patients].
June 1976, Bollettino della Societa italiana di biologia sperimentale,
K Blennow, and A Wallin, and C G Gottfries, and A Lekman, and I Karlsson, and I Skoog, and L Svennerholm
Evidence for an association between the CSF HVA:5-HIAA ratio and aggressiveness in frontotemporal dementia but not in Alzheimer's disease.
July 2004, Journal of neurology, neurosurgery, and psychiatry,
K Blennow, and A Wallin, and C G Gottfries, and A Lekman, and I Karlsson, and I Skoog, and L Svennerholm
CSF 5-HIAA and HVA concentrations in elderly depressed patients who attempted suicide.
September 1990, The American journal of psychiatry,
K Blennow, and A Wallin, and C G Gottfries, and A Lekman, and I Karlsson, and I Skoog, and L Svennerholm
Determination of HVA and 5-HIAA in ventricular CSF of patients with brain tumors.
January 1974, Journal of neurosurgical sciences,
K Blennow, and A Wallin, and C G Gottfries, and A Lekman, and I Karlsson, and I Skoog, and L Svennerholm
Probenecid: dosage, levels in plasma and cerebrospinal fluid (CSF) and influence upon CSF levels of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the rabbit.
September 1975, Psychopharmacologia,
K Blennow, and A Wallin, and C G Gottfries, and A Lekman, and I Karlsson, and I Skoog, and L Svennerholm
Lateral ventricle-brain ratio and balance between CSF HVA and 5-HIAA in schizophrenia.
September 1991, The American journal of psychiatry,
Copied contents to your clipboard!